|
| Commodity | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
| Penicillins & their derivs. with a penicillanic acid structure; salts there ... | $227,471,978 | $370,068,912 | $637,843,147 | $611,870,828 | $461,989,355 | $578,259,122 | $595,382,484 |
| Streptomycins & their derivs.; salts thereof | $31,260,841 | $28,552,740 | $37,459,037 | $38,153,113 | $31,564,278 | $37,142,748 | $52,707,618 |
| Tetracyclines & their derivs.; salts thereof | $174,814,098 | $171,732,099 | $183,174,772 | $191,562,336 | $181,730,874 | $206,588,698 | $352,615,359 |
| Chloramphenicol & its derivs.; salts thereof | $26,296,027 | $31,706,650 | $35,195,909 | $48,606,261 | $83,230,757 | $90,796,183 | $130,939,344 |
| Erythromycin & its derivs.; salts thereof | $75,061,188 | $97,279,806 | $97,982,552 | $149,078,934 | $169,042,701 | $275,350,990 | $370,144,312 |
| Antibiotics & their derivs. (excl. of 2941.10-2941.50); salts thereof | $654,638,319 | $806,063,207 | $1,086,560,192 | $1,324,506,990 | $1,335,371,622 | $1,701,640,729 | $1,585,359,772 |
| Total | $1,189,542,451 | $1,505,403,414 | $2,078,215,609 | $2,363,778,462 | $2,262,929,587 | $2,889,778,470 | $3,087,148,889 |
|
|
